Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Debt to Equity (2022 - 2024)

Gossamer Bio's Debt to Equity history spans 3 years, with the latest figure at $0.36 for Q1 2024.

  • For Q1 2024, Debt to Equity rose 149.01% year-over-year to $0.36; the TTM value through Mar 2024 reached $0.36, up 149.01%, while the annual FY2023 figure was $0.2, 89.87% down from the prior year.
  • Debt to Equity reached $0.36 in Q1 2024 per GOSS's latest filing, up from $0.2 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.95 in Q4 2022 to a low of -$1.07 in Q2 2022.
  • Average Debt to Equity over 3 years is $0.2, with a median of $0.2 recorded in 2023.
  • Peak YoY movement for Debt to Equity: plummeted 175.7% in 2023, then skyrocketed 149.01% in 2024.
  • A 3-year view of Debt to Equity shows it stood at $1.95 in 2022, then plummeted by 89.87% to $0.2 in 2023, then surged by 81.25% to $0.36 in 2024.
  • Per Business Quant, the three most recent readings for GOSS's Debt to Equity are $0.36 (Q1 2024), $0.2 (Q4 2023), and $0.15 (Q3 2023).